Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

Having multiple treatment options is the kind of advancement we’ve all been waiting for ... scientists and clinicians ...

Targeting toxic oligomers without binding to plaque, designed to reduce the risk of ARIA and potentially deliver enhanced ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

The treatment is not a permanent fix for Alzheimer's dementia, Jing said, because the disease will eventually ... It's important for them to know there are options out there." ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease ... Alzheimer's Treatment One Step ...

8, 2025 — Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease ... VU319 Brings Alzheimer's Treatment One Step Closer ...

Summary: Researchers have linked chronic intestinal infections caused by cytomegalovirus (HCMV) to a unique subtype of Alzheimer’s disease. The virus may travel from the gut to ... test to identify ...